Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2026)

Insight Molecular Diagnostics has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.06 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.06, down 26.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.06 (down 26.86% YoY), and the FY2025 annual result was 0.13, up 289.69% from the prior year.
• Asset Utilization Ratio came in at 0.06 for Q1 2026 at Insight Molecular Diagnostics, down from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.12 in Q4 2025 to a low of 0.01 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.03 (2022), against an average of 0.04.
• Across the five-year window, Asset Utilization Ratio plunged 84.21% in 2022 and soared 852.71% in 2025, its largest moves.
• Insight Molecular Diagnostics' Asset Utilization Ratio stood at 0.01 in 2022, then soared by 158.11% to 0.02 in 2023, then jumped by 85.98% to 0.04 in 2024, then surged by 225.71% to 0.12 in 2025, then slumped by 49.39% to 0.06 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.06 (Q1 2026), 0.12 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.